Omniox, Inc.
PrivateLast Round
Convertible Debt
Mar 30, 2026
Total Funding Raised
$61.57M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Omniox, Inc. is a biopharmaceutical company developing oxygen-delivery therapeutics to treat a range of diseases, including solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Omniox, Inc. Comparables
Compare Omniox, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NuvOx Therapeutics | 81% | |
| Prolong Pharmaceuticals, LLC | 80% | |
| Aurum Biosciences Ltd | 73% |
Omniox, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Mar 30, 2026 | ||||
| Grant | Jan 22, 2024 | ||||
| Early Funding | Nov 1, 2023 | ||||
| Series D | Mar 23, 2018 | ||||
| Grant | Aug 2, 2017 | ||||
Grant | Sep 1, 2016 |
Omniox, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| Wavemaker Three-Sixty Health | Early Funding |
| Samsara BioCapital | Early Funding |
| Medical Technology Enterprise Consortium | Grant |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | Grant |
| Wellcome Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 435% MoM to 5.2K.
- Jul 25, 2026
Monthly visitors increased 112% MoM.
Omniox, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Omniox, Inc.'s valuation, stock price, and market status.
Is Omniox, Inc. a public or private company?
Omniox, Inc. is a private company.
What is the current stock price of Omniox, Inc.?
Omniox, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Omniox, Inc. worth (valuation)?
Valuation information for Omniox, Inc. is not publicly available.
Can I buy Omniox, Inc. stock?
Omniox, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Omniox, Inc.'s last funding round?
Omniox, Inc.'s most recent funding round was Early Stage VC on March 30, 2026.
Who are the main investors in Omniox, Inc.?
Key investors in Omniox, Inc. include National Cancer Institute, Wellcome Trust.
Will Omniox, Inc. IPO soon?
No public IPO plans have been announced for Omniox, Inc..
How can I track Omniox, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Omniox, Inc.'s secondary market activity and sign up for updates.